Comstock reports $16.4 million non-cash impairment; Mackay legacy asset sale pending
Comstock Inc. announced second quarter 2026 results on July 23, 2026, including a $16.4 million non-cash impairment tied to Bioleum technologies it no longer considers relevant. The release does not state quarterly revenue or earnings per share, but it reports $31.4 million in cash at June 30, 2026, and a pending sale of legacy mining assets to Mackay for total consideration of over $45.0 million.
Key points
- Impairment of approximately $16.4 million, substantially all non-cash, tied to Flux Photon and related Bioleum technologies
- Cash and cash equivalents of $31.4 million at June 30, 2026; 75.95 million common shares outstanding at that date
- Mackay sale of legacy mining assets: total consideration over $45.0 million, expected to close in August 2026
- Management expects about $5 million in solar recycling revenue in the second half of 2026
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 24, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.